shares in angloswedish drug have closed down 8 in uk trade after the failure of its iressa drug in a major clinical trialjohn patterson will be in charge of drug developmentastrazeneca had hoped to pitch its iressa drug against rival medicine tarcevathe lung cancer drug did not significantly prolong survival in patients with the diseasethis would be two of the three blockbuster drugs that were meant to power the company forward failing
and weve got risks on crestor said nick turner analyst at brokers jefferies
